Soleno Therapeutics
SLNO52
$76.73arrow_drop_up3.34%$2.47
SLNO52
$76.73
arrow_drop_up3.34%| Key Stats | |
|---|---|
| Open | $73.63 |
| Prev. Close | $73.89 |
| EPS | -4.38 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 69.34 | 76.83 |
| 52 Week Range | 21.30 | 80.50 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -4.38 |
| Fundamentals | |
|---|---|
| RPS | - |
| Gross Profit | - |
| Total Debt | - |
| Payout Ratio | - |
| Industry average yield | 2.89% |
| Last Dividend pay date | Oct 6, 2017 |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
SLNO-
US Healthcare Sector-
US Market-
check_circle
SLNO / Market
SLNO exceeded the US Market which returned 0.03% over the last twenty four hours.check_circle
SLNO / Healthcare Sector
SLNO exceeded the US Healthcare sector which returned 2.60% over the last twenty four hours.Soleno Therapeutics (SLNO) Statistics
Keep an eye on Soleno Therapeutics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Soleno Therapeutics (SLNO) stock's performance compared to its sector and the market over the past year?
Over the past year, Soleno Therapeutics (SLNO) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Soleno Therapeutics has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Soleno Therapeutics 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Soleno Therapeutics (SLNO) stock?
The PE ratio for Soleno Therapeutics (SLNO) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of Soleno Therapeutics (SLNO) stock?
The Earnings Per Share (EPS) for Soleno Therapeutics (SLNO), calculated on a diluted basis, is -$4.38. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Soleno Therapeutics (SLNO) stock?
The operating margin for Soleno Therapeutics (SLNO) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Soleno Therapeutics (SLNO) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Soleno Therapeutics (SLNO) is -$182.45M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Soleno Therapeutics (SLNO) have?
The total debt for Soleno Therapeutics (SLNO) is currently not available. The net debt for Soleno Therapeutics (SLNO) is currently not available.